Clinical Research on BLIS M18 Indicates Dose Dependency and Safety

New research published in the journal PLoS ONE provides more evidence that the Streptococcus salivarius M18 probiotic, branded as BLIS M18, will provide enhanced benefits for maintaining the health of the oral cavity. The research was carried out in a collaboration between Western University (London, Ontario) and the developer of the probiotic, BLIS Technologies Ltd ...